|
In 1995, a routine blood test changed Diana Gallagher’s life. It
revealed that she had developed a rare blood disorder she had
never heard of: essential thrombocythemia (ET).
People with ET make too many platelets, parts of the
blood that help it clot. An excess of platelets can lead to
spontaneous blood clots or bleeding. No one knows what
causes the high platelet count, and many have no warning
signs that they have the disease.
Stunned by the diagnosis, Gallagher started treatment
near her Las Vegas home. In 2001, she moved to Los Angeles
and continued care at a local hospital but her condition
worsened. Her son heard about City of Hope and “he pleaded
with me to go,” she said.
There, she met Leslie L. Popplewell, M.D., clinical
associate professor in the Department of Hematology &
Hematopoietic Cell Transplantation. “Diana’s condition
evolved, and she now has what is called ‘myeloproliferative
syndrome,’ which includes excess production of fibrous bone
marrow tissue,” Popplewell said.
Several years ago, Gallagher began needing a blood
transfusion every few weeks to offset the anemia that can
leave her exhausted. In addition, she takes a daily
chemotherapy pill to help control her excess platelet
production.
She lives almost an hour’s drive away from
the Michael Amini Transfusion Medicine Center at
City of Hope, but the drive is worth it. “I feel so
much better after each transfusion,” she said. “I
have energy again.”
Gallagher also takes care of herself with yoga
and meditation. For now, her blood counts are
up. “Knock wood,” she said, “I went three months
between transfusions and I’m feeling good.” She
knows that City of Hope — and the people who
donate blood and platelets — will be there when she
needs them.
“From the bottom of my heart, I thank every one
of the people who donate blood,” said Gallagher. “It’s
so important. It has saved my life.”
|